AKERO THERAPEUTICS INC shareholders Q3 2023

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 4,425$223,8170.18%
Campbell & CO Investment Adviser LLC 29,649$1,499,6460.18%
Caption Management, LLC 205,300$10,384,0740.16%
JANUS HENDERSON GROUP PLC 4,486,726$226,952,2170.15%
LORD, ABBETT & CO. LLC 779,126$39,4090.15%
PEREGRINE CAPITAL MANAGEMENT LLC 95,447$4,827,7090.14%
Holocene Advisors, LP 586,300$29,655,0540.13%
FRED ALGER MANAGEMENT, LLC 441,086$22,310,1300.13%
Knott David M Jr 6,419$3250.12%
Caption Management, LLC 143,000$7,232,9400.11%
BOOTHBAY FUND MANAGEMENT, LLC 80,500$4,071,6900.10%
MOORE CAPITAL MANAGEMENT, LP 102,400$5,179,3920.10%
GSA CAPITAL PARTNERS LLP 20,597$1,0420.09%
PROFUND ADVISORS LLC 31,222$1,579,2090.09%
Schonfeld Strategic Advisors LLC 212,008$10,723,3640.08%
XTX Topco Ltd 8,122$410,8110.07%
Virtus ETF Advisers LLC 1,795$90,7910.06%
Rafferty Asset Management, LLC 183,497$9,281,2780.06%
Trexquant Investment LP 42,620$2,155,7200.05%
TWINBEECH CAPITAL LP 54,780$2,770,7720.05%
External links

This page lists AKERO THERAPEUTICS INC's shareholders in Q3 2023. To view AKERO THERAPEUTICS INC's shareholder history, click here.